Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2506739073', 'doi': 'https://doi.org/10.1016/j.clinthera.2016.07.004', 'title': 'Prescribing Patterns of Oral Antineoplastic Therapies Observed in the Treatment of Patients With Advanced Prostate Cancer Between 2012 and 2014: Results of an Oncology EMR Analysis', 'display_name': 'Prescribing Patterns of Oral Antineoplastic Therapies Observed in the Treatment of Patients With Advanced Prostate Cancer Between 2012 and 2014: Results of an Oncology EMR Analysis', 'publication_year': 2016, 'publication_date': '2016-08-01', 'ids': {'openalex': 'https://openalex.org/W2506739073', 'doi': 'https://doi.org/10.1016/j.clinthera.2016.07.004', 'mag': '2506739073', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27491282'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.clinthera.2016.07.004', 'pdf_url': 'http://www.clinicaltherapeutics.com/article/S0149291816304465/pdf', 'source': {'id': 'https://openalex.org/S185879095', 'display_name': 'Clinical Therapeutics', 'issn_l': '0149-2918', 'issn': ['0149-2918', '1879-114X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'http://www.clinicaltherapeutics.com/article/S0149291816304465/pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5067577806', 'display_name': 'Elisabetta Malangone-Monaco', 'orcid': 'https://orcid.org/0000-0002-4993-9268'}, 'institutions': [{'id': 'https://openalex.org/I189504160', 'display_name': 'Truven Health Analytics (United States)', 'ror': 'https://ror.org/00sf52z42', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I189504160']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Elisabetta Malangone-Monaco', 'raw_affiliation_strings': ['Truven Health Analytics, Inc, Bethesda, Maryland'], 'affiliations': [{'raw_affiliation_string': 'Truven Health Analytics, Inc, Bethesda, Maryland', 'institution_ids': ['https://openalex.org/I189504160']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103642905', 'display_name': 'Kathleen A. Foley', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I189504160', 'display_name': 'Truven Health Analytics (United States)', 'ror': 'https://ror.org/00sf52z42', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I189504160']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kathleen Foley', 'raw_affiliation_strings': ['Truven Health Analytics, Inc, Bethesda, Maryland'], 'affiliations': [{'raw_affiliation_string': 'Truven Health Analytics, Inc, Bethesda, Maryland', 'institution_ids': ['https://openalex.org/I189504160']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051420725', 'display_name': 'Helen Varker', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I189504160', 'display_name': 'Truven Health Analytics (United States)', 'ror': 'https://ror.org/00sf52z42', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I189504160']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Helen Varker', 'raw_affiliation_strings': ['Truven Health Analytics, Inc, Bethesda, Maryland'], 'affiliations': [{'raw_affiliation_string': 'Truven Health Analytics, Inc, Bethesda, Maryland', 'institution_ids': ['https://openalex.org/I189504160']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085738876', 'display_name': 'Kathleen Wilson', 'orcid': 'https://orcid.org/0000-0003-0523-0625'}, 'institutions': [{'id': 'https://openalex.org/I189504160', 'display_name': 'Truven Health Analytics (United States)', 'ror': 'https://ror.org/00sf52z42', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I189504160']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kathleen L. Wilson', 'raw_affiliation_strings': ['Truven Health Analytics, Inc, Bethesda, Maryland'], 'affiliations': [{'raw_affiliation_string': 'Truven Health Analytics, Inc, Bethesda, Maryland', 'institution_ids': ['https://openalex.org/I189504160']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051418621', 'display_name': 'Scott McKenzie', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210151386', 'display_name': 'Janssen (United States)', 'ror': 'https://ror.org/05af73403', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4210151386']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Scott McKenzie', 'raw_affiliation_strings': ['Janssen Pharmaceuticals, LLC, Horsham, Pennsylvania'], 'affiliations': [{'raw_affiliation_string': 'Janssen Pharmaceuticals, LLC, Horsham, Pennsylvania', 'institution_ids': ['https://openalex.org/I4210151386']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5033380416', 'display_name': 'Lorie Ellis', 'orcid': 'https://orcid.org/0000-0002-9798-6982'}, 'institutions': [{'id': 'https://openalex.org/I4210151386', 'display_name': 'Janssen (United States)', 'ror': 'https://ror.org/05af73403', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4210151386']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lorie Ellis', 'raw_affiliation_strings': ['Janssen Pharmaceuticals, LLC, Horsham, Pennsylvania'], 'affiliations': [{'raw_affiliation_string': 'Janssen Pharmaceuticals, LLC, Horsham, Pennsylvania', 'institution_ids': ['https://openalex.org/I4210151386']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5067577806'], 'corresponding_institution_ids': ['https://openalex.org/I189504160'], 'apc_list': {'value': 4210, 'currency': 'USD', 'value_usd': 4210, 'provenance': 'doaj'}, 'apc_paid': {'value': 4210, 'currency': 'USD', 'value_usd': 4210, 'provenance': 'doaj'}, 'fwci': 1.882, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 16, 'citation_normalized_percentile': {'value': 0.859656, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '38', 'issue': '8', 'first_page': '1817', 'last_page': '1824'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 0.9779, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11395', 'display_name': 'Radiopharmaceutical Chemistry and Applications', 'score': 0.9778, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.9717686}, {'id': 'https://openalex.org/keywords/abiraterone-acetate', 'display_name': 'Abiraterone acetate', 'score': 0.93963885}, {'id': 'https://openalex.org/keywords/abiraterone', 'display_name': 'Abiraterone', 'score': 0.46496373}, {'id': 'https://openalex.org/keywords/medical-record', 'display_name': 'Medical record', 'score': 0.46154195}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.9717686}, {'id': 'https://openalex.org/C2775832370', 'wikidata': 'https://www.wikidata.org/wiki/Q27888393', 'display_name': 'Abiraterone acetate', 'level': 5, 'score': 0.93963885}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9146558}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.75166327}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.48906025}, {'id': 'https://openalex.org/C2776421732', 'wikidata': 'https://www.wikidata.org/wiki/Q27888393', 'display_name': 'Abiraterone', 'level': 5, 'score': 0.46496373}, {'id': 'https://openalex.org/C195910791', 'wikidata': 'https://www.wikidata.org/wiki/Q1324077', 'display_name': 'Medical record', 'level': 2, 'score': 0.46154195}, {'id': 'https://openalex.org/C2781190966', 'wikidata': 'https://www.wikidata.org/wiki/Q420436', 'display_name': 'Docetaxel', 'level': 3, 'score': 0.4442104}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.4434792}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.41670856}, {'id': 'https://openalex.org/C2777899217', 'wikidata': 'https://www.wikidata.org/wiki/Q4759439', 'display_name': 'Androgen deprivation therapy', 'level': 4, 'score': 0.110167325}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.clinthera.2016.07.004', 'pdf_url': 'http://www.clinicaltherapeutics.com/article/S0149291816304465/pdf', 'source': {'id': 'https://openalex.org/S185879095', 'display_name': 'Clinical Therapeutics', 'issn_l': '0149-2918', 'issn': ['0149-2918', '1879-114X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.clinthera.2016.07.004', 'pdf_url': 'http://www.clinicaltherapeutics.com/article/S0149291816304465/pdf', 'source': {'id': 'https://openalex.org/S185879095', 'display_name': 'Clinical Therapeutics', 'issn_l': '0149-2918', 'issn': ['0149-2918', '1879-114X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/10', 'display_name': 'Reduced inequalities', 'score': 0.75}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 16, 'referenced_works': ['https://openalex.org/W150725082', 'https://openalex.org/W2006622171', 'https://openalex.org/W2077438659', 'https://openalex.org/W2091384457', 'https://openalex.org/W2103959341', 'https://openalex.org/W2110534364', 'https://openalex.org/W2120292596', 'https://openalex.org/W2123526148', 'https://openalex.org/W2135620818', 'https://openalex.org/W2137467802', 'https://openalex.org/W2147887481', 'https://openalex.org/W2148643283', 'https://openalex.org/W2159810380', 'https://openalex.org/W2166918329', 'https://openalex.org/W2169258216', 'https://openalex.org/W2201330717'], 'related_works': ['https://openalex.org/W3156855168', 'https://openalex.org/W2989383552', 'https://openalex.org/W2982156914', 'https://openalex.org/W2935114107', 'https://openalex.org/W2776594178', 'https://openalex.org/W2768688864', 'https://openalex.org/W2768013934', 'https://openalex.org/W2338519528', 'https://openalex.org/W2162738516', 'https://openalex.org/W122177069'], 'abstract_inverted_index': {'PurposeThe': [0], 'purpose': [1], 'of': [2, 47, 52, 109, 128, 135, 138, 146, 159, 174, 197, 209, 214, 232, 243, 266, 274, 287, 295, 301], 'this': [3], 'study': [4, 39, 140, 163, 169, 279], 'was': [5, 101, 156, 202, 255], 'to': [6, 125, 226, 238, 248, 284], 'examine,': [7], 'using': [8], 'a': [9, 45, 94, 115, 194, 257], 'US': [10, 288], 'electronic': [11], 'medical': [12, 111, 129], 'records': [13], '(EMR)': [14], 'database,': [15], 'the': [16, 61, 102, 122, 126, 136, 139, 172, 203, 282], 'clinical': [17], 'characteristics': [18], 'and': [19, 68, 86, 114, 148, 165, 189, 241, 271, 299], 'real-world': [20], 'treatment': [21, 31, 76, 178, 207, 261], 'sequences': [22], 'in': [23, 60, 264, 272, 304], 'men': [24], 'with': [25, 32, 44, 77, 179, 218, 253, 306], 'advanced': [26, 152, 307], 'prostate': [27, 48, 153, 308], 'cancer': [28, 49, 154], 'who': [29, 72, 176], 'initiated': [30, 74, 177], 'abiraterone': [33, 78, 97, 181, 200, 220, 234, 250, 268], 'acetate': [34, 79, 98, 182, 201, 221], 'or': [35, 80, 99, 133, 183, 222], 'enzalutamide.MethodsThis': [36], 'retrospective,': [37], 'observational': [38], 'evaluated': [40], 'adult': [41], 'male': [42], 'patients': [43, 161, 175, 215, 236, 246, 270, 305], 'diagnosis': [46], '(International': [50], 'Classification': [51], 'Diseases,': [53], 'Ninth': [54], 'Revision,': [55], 'Clinical': [56], 'Modification': [57], 'code': [58], '185)': [59], 'EMR': [62, 278], 'database': [63], 'between': [64, 82, 185], 'July': [65], '1,': [66, 84, 187], '2011,': [67], 'March': [69, 87, 190], '31,': [70, 88, 142, 191], '2014,': [71, 192], 'had': [73, 106], 'first-line': [75, 206, 210, 217, 233, 244, 267, 275], 'enzalutamide': [81, 100, 184, 223], 'September': [83, 186], '2012,': [85, 188], '2014.': [89], 'The': [90, 144], 'first': [91, 283], 'record': [92, 112, 130], 'for': [93, 151], 'patient': [95], 'initiating': [96], 'index': [103, 123], 'date.': [104], 'Patients': [105], '6': [107], 'months': [108], 'pre-index': [110], 'history': [113], 'variable': [116], 'length': [117], 'follow-up': [118], 'period,': [119], 'extending': [120], 'from': [121], 'date': [124, 134], 'end': [127, 137], 'data': [131], 'availability': [132], '(March': [141], '2014).': [143], 'sequence': [145], 'first-': [147], 'second-line': [149, 229, 239, 249, 260], 'therapies': [150, 303], 'therapy': [155, 198], 'reported.FindingsA': [157], 'total': [158], '809': [160], 'met': [162], 'inclusion': [164], 'exclusion': [166], 'criteria.': [167], 'This': [168], 'found': [170], 'that': [171], 'majority': [173], 'either': [180, 219], 'received': [193], 'single': [195], 'line': [196], '(72%);': [199], 'most': [204], 'common': [205], '(74%': [208], 'patients).': [211], 'A': [212], 'subset': [213], 'treated': [216], 'were': [224], 'transitioned': [225, 237, 247], 'an': [227], 'oral': [228, 296], 'agent': [230], '(17%': [231], 'acetate–treated': [235, 269], 'enzalutamide,': [240], '16%': [242], 'enzalutamide-treated': [245, 276], 'acetate).': [251], 'Chemotherapy': [252], 'docetaxel': [254], 'also': [256], 'commonly': [258], 'observed': [259], 'selection,': [262], 'occurring': [263], '8%': [265], '7%': [273], 'patients.ImplicationsThis': [277], 'is': [280], 'among': [281], 'present': [285], 'evidence': [286], 'physician': [289], 'practice': [290], 'prescribing': [291], 'patterns': [292], 'regarding': [293], 'initiation': [294], 'antineoplastic': [297], 'agents': [298], 'use': [300], 'subsequent': [302], 'cancer.': [309]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2506739073', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 5}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 4}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}], 'updated_date': '2024-12-13T14:00:14.842857', 'created_date': '2016-08-23'}